Press Releases
CLSI Susceptibility Data Compilation and Storage Guideline For Effective Use of Cumulative Susceptiblity Statistics (M39-A2)

CLSI Susceptibility Data Compilation and Storage Guideline For Effective Use of Cumulative Susceptiblity Statistics
CLSI document M39-A2—Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline—Second Edition assists the preparation of cumulative antimicrobial susceptibility reports that will prove useful to clinicians in the selection of the most appropriate agents for initial empiric antimicrobial therapy.  M39-A2 also includes examples for presenting data generated when not all antimicrobial agents are tested on each isolate; added suggestions for information that might be highlighted when presenting cumulative antibiogram reports to healthcare professionals; expanded recommendations for presenting data to reflect emerging resistance trends; and added suggestions for reviewing a completed cumulative antibiogram prior to distribution.
Full press release

Risk Management Tools for Improved Patient Safety Workshop Announced by Clinical and Laboratory Standards Institute
Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) has announced it will follow up March 2005’s groundbreaking Quality Control for the Future workshop with a workshop titled Risk Management Tools for Improved Patient Safety, to take place in conjunction with the organization’s annual Leadership Conference, from 26-28 April 2006 in Vienna, Virginia, outside of Washington, DC.  Risk Management Tools for Improved Patient Safety will focus specifically upon defining current problems in risk management, reviewing currently employed mechanisms and solutions, and describing a systematic risk management approach, providing attendees with concrete tools with which to return to their workplaces for practical application.
Full press release

CLSI and COLA Announce New Partnership
Laboratory accreditation leader COLA and global standards-development organization Clinical and Laboratory Standards Institute (CLSI) today announced a partnership that fits the respective missions of the two organizations, directly linking best practice standards, guidelines, and educational services to regulatory compliance and laboratory accreditation.  Under the agreement, CLSI will develop a collection of consensus documents specifically designed for the clinical laboratory, which complements COLA’s unique online education program on quality management systems. 
Full press release

CLSI Guideline to Aid Labs in Detecting Error Caused by Interfering Substances
Measurement errors caused by interfering substances may put patients at risk.  Even while internal quality control systems monitor precision, and reference materials or procedures can be used to verify accuracy, it remains a difficult task for laboratories to detect error caused by interfering substances.  Therefore, manufacturers of in vitro diagnostic (IVD) analytical systems must include evaluation of the effects of the potentially interfering substances in their risk analyses at the design stage.
Full press release

CLSI Receives Cooperative Agreement to Improve HIV Testing Worldwide
Global standards-development organization Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) has received a $365,000 USD cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS/CDC) for capacity-building assistance for global HIV/AIDS laboratory guidelines and standards development.  The year-long agreement is funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), which the U.S. Department of State describes as “the largest commitment ever by a single nation toward an international health initiative.”
Full press release

  [ return to top ]